source
- Lundbeck plans US headquarters move to Boston to boost neuroscience R&DLundbeck, a Danish pharmaceutical company focused on neuroscience, announced it will relocate its U.S. operations to Boston. The move is part of a broader strategy to concentrate R&D on increasing…
- Jury awards Nektar $90 million in lawsuit against Eli Lilly over licensing disputeA federal jury in a US District Court awarded Nektar Therapeutics $90 million after finding Eli Lilly breached a licensing agreement. The verdict ends a dispute that began when the parties' licens…